Evidence map›Paper›PMID 31493132›Full record

ReviewPurinergic signalling2019

Role of purines in regulation of metabolic reprogramming.

Zhenwei Tang, Wenrui Ye, Haotian Chen, Xinwei Kuang, Jia Guo, Minmin Xiang, Cong Peng, Xiang Chen, Hong Liu

Open access · bronzeAbstract readReview
In one paragraph

Review in Purinergic signalling, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Metabolic dysregulation in Alzheimer's disease: A brain metabolomics approach.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. The intersection of hostMicrobiology and molecular biology reviews : MMBR · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Zhenwei TangDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Wenrui YeClinical Medicine Eight-Year Program, Xiangya Medical School of Central South University, Changsha, Hunan, China.
Haotian ChenClinical Medicine Eight-Year Program, Xiangya Medical School of Central South University, Changsha, Hunan, China.
Xinwei KuangDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Jia GuoDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Minmin XiangDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Cong PengDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Xiang ChenDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China. chenxiangck@126.com.
Hong LiuDepartment of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China. hongliu1014@csu.edu.cn.
Central South University · CNXiangya Hospital Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purines, among most influential molecules, are reported to have essential biological function by regulating various cell types. A large number of studies have led to the discovery of many biological functions of the purine nucleotides such as ATP, ADP, and adenosine, as signaling molecules that engage G protein-coupled or ligand-gated ion channel receptors. The role of purines in the regulation of cellular functions at the gene or protein level has been well documented. With the advances in multiomics, including those from metabolomic and bioinformatic analyses, metabolic reprogramming was identified as a key mechanism involved in the regulation of cellular function under physiological or pathological conditions. Recent studies suggest that purines or purine-derived products contribute to important regulatory functions in many fundamental biological and pathological processes related to metabolic reprogramming. Therefore, this review summarizes the role and potential mechanism of purines in the regulation of metabolic reprogramming. In particular, the molecular mechanisms of extracellular purine- and intracellular purine-mediated metabolic regulation in various cells during disease development are discussed. In summary, our review provides an extensive resource for studying the regulatory role of purines in metabolic reprogramming and sheds light on the utilization of the corresponding peptides or proteins for disease diagnosis and therapy.

Indexed as

AdenosineAdenosine TriphosphateAnimalsHumansMolecular Targeted TherapyPurinesSignal TransductionAdenosineAdenosine TriphosphatepurinePurinesMetabolic reprogrammingPurinesSignal transductionTarget therapy

Identifiers

PMID31493132
PMCPMC6923298
OpenAlexW2971763900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.